41 related articles for article (PubMed ID: 8552301)
1. Sulfonated dyes attenuate the toxic effects of beta-amyloid in a structure-specific fashion.
Pollack SJ; Sadler II; Hawtin SR; Tailor VJ; Shearman MS
Neurosci Lett; 1995 Sep; 197(3):211-4. PubMed ID: 8552301
[TBL] [Abstract][Full Text] [Related]
2. A Biomimetic Multiparametric Assay to Characterise Anti-Amyloid Drugs.
Smeralda W; Since M; Corvaisier S; Fayolle D; Cardin J; Duprey S; Jourdan JP; Cullin C; Malzert-Freon A
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069305
[TBL] [Abstract][Full Text] [Related]
3. Heparan Sulfate as a Therapeutic Target in Tauopathies: Insights From Zebrafish.
Alavi Naini SM; Soussi-Yanicostas N
Front Cell Dev Biol; 2018; 6():163. PubMed ID: 30619849
[TBL] [Abstract][Full Text] [Related]
4. Atomic structures of corkscrew-forming segments of SOD1 reveal varied oligomer conformations.
Sangwan S; Sawaya MR; Murray KA; Hughes MP; Eisenberg DS
Protein Sci; 2018 Jul; 27(7):1231-1242. PubMed ID: 29453800
[TBL] [Abstract][Full Text] [Related]
5. Small-molecule theranostic probes: a promising future in neurodegenerative diseases.
Aulić S; Bolognesi ML; Legname G
Int J Cell Biol; 2013; 2013():150952. PubMed ID: 24324497
[TBL] [Abstract][Full Text] [Related]
6. Halogenation generates effective modulators of amyloid-Beta aggregation and neurotoxicity.
Wong HE; Irwin JA; Kwon I
PLoS One; 2013; 8(2):e57288. PubMed ID: 23468958
[TBL] [Abstract][Full Text] [Related]
7. Keampferol-3-O-rhamnoside abrogates amyloid beta toxicity by modulating monomers and remodeling oligomers and fibrils to non-toxic aggregates.
Sharoar MG; Thapa A; Shahnawaz M; Ramasamy VS; Woo ER; Shin SY; Park IS
J Biomed Sci; 2012 Dec; 19(1):104. PubMed ID: 23259691
[TBL] [Abstract][Full Text] [Related]
8. A safe, blood-brain barrier permeable triphenylmethane dye inhibits amyloid-β neurotoxicity by generating nontoxic aggregates.
Wong HE; Qi W; Choi HM; Fernandez EJ; Kwon I
ACS Chem Neurosci; 2011 Nov; 2(11):645-57. PubMed ID: 22860159
[TBL] [Abstract][Full Text] [Related]
9. Xanthene food dye, as a modulator of Alzheimer's disease amyloid-beta peptide aggregation and the associated impaired neuronal cell function.
Wong HE; Kwon I
PLoS One; 2011; 6(10):e25752. PubMed ID: 21998691
[TBL] [Abstract][Full Text] [Related]
10. Effects of heparin and enoxaparin on APP processing and Aβ production in primary cortical neurons from Tg2576 mice.
Cui H; Hung AC; Klaver DW; Suzuki T; Freeman C; Narkowicz C; Jacobson GA; Small DH
PLoS One; 2011; 6(7):e23007. PubMed ID: 21829577
[TBL] [Abstract][Full Text] [Related]
11. Structurally distinct toxicity inhibitors bind at common loci on β-amyloid fibril.
Keshet B; Gray JJ; Good TA
Protein Sci; 2010 Dec; 19(12):2291-304. PubMed ID: 20882638
[TBL] [Abstract][Full Text] [Related]
12. Anti-Amyloid Effects of Small Molecule Aβ-Binding Agents in PS1/APP Mice.
Cohen AD; Ikonomovic MD; Abrahamson EE; Paljug WR; Dekosky ST; Lefterov IM; Koldamova RP; Shao L; Debnath ML; Mason NS; Mathis CA; Klunk WE
Lett Drug Des Discov; 2009 Sep; 6(6):437. PubMed ID: 20119496
[TBL] [Abstract][Full Text] [Related]
13. Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.
Yamin G; Ono K; Inayathullah M; Teplow DB
Curr Pharm Des; 2008; 14(30):3231-46. PubMed ID: 19075703
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective properties of glycosaminoglycans: potential treatment for neurodegenerative disorders.
Dudas B; Rose M; Cornelli U; Pavlovich A; Hanin I
Neurodegener Dis; 2008; 5(3-4):200-5. PubMed ID: 18322390
[TBL] [Abstract][Full Text] [Related]
15. The effects of sodium sulfate, glycosaminoglycans, and Congo red on the structure, stability, and amyloid formation of an immunoglobulin light-chain protein.
McLaughlin RW; De Stigter JK; Sikkink LA; Baden EM; Ramirez-Alvarado M
Protein Sci; 2006 Jul; 15(7):1710-22. PubMed ID: 16751605
[TBL] [Abstract][Full Text] [Related]
16. Common structural features determine the effectiveness of carvedilol, daunomycin and rolitetracycline as inhibitors of Alzheimer beta-amyloid fibril formation.
Howlett DR; George AR; Owen DE; Ward RV; Markwell RE
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):419-23. PubMed ID: 10510309
[TBL] [Abstract][Full Text] [Related]
17. An atomic model for the pleated beta-sheet structure of Abeta amyloid protofilaments.
Li L; Darden TA; Bartolotti L; Kominos D; Pedersen LG
Biophys J; 1999 Jun; 76(6):2871-8. PubMed ID: 10354415
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans.
Howlett DR; Perry AE; Godfrey F; Swatton JE; Jennings KH; Spitzfaden C; Wadsworth H; Wood SJ; Markwell RE
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):283-9. PubMed ID: 10229684
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to a 100-kd protein reveal abundant A beta-negative plaques throughout gray matter of Alzheimer's disease brains.
Schmidt ML; Lee VM; Forman M; Chiu TS; Trojanowski JQ
Am J Pathol; 1997 Jul; 151(1):69-80. PubMed ID: 9212733
[TBL] [Abstract][Full Text] [Related]
20. Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia.
Giulian D; Haverkamp LJ; Yu JH; Karshin W; Tom D; Li J; Kirkpatrick J; Kuo LM; Roher AE
J Neurosci; 1996 Oct; 16(19):6021-37. PubMed ID: 8815885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
